THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
First IMI Ebola projects get underway
IMI is launching the first eight projects of its Ebola+ programme, covering vaccine development, manufacture and uptake as well as diagnostics.
- Read the press release
- 03/03/2015 : RT @WHO: Dr Chan: Three #Ebola vaccines trials are underway. We need more research to find whether the vaccines are efficacious #EbolaRespo…
- 03/03/2015 : RT @EU_Commission: #EbolaResponse: EU mobilises efforts to end #Ebola & alleviate its impact http://t.co/zS0PKtU3AG http://t.co/r5DYnBlV5O
- 03/03/2015 : RT @Open_PHACTS: Do you use Open PHACTS in your research? Want to present your work at a conference? Our travel grants can help! http://t.c…